Schafer Cullen Capital Management’s Medtronic MDT Stock Holding History

Schafer Cullen Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$8.75M	Sell	74,080 -1,060,948	-93%	-$124M	1.78%	27
2020 Q4	$133M	Sell	1,135,028 -88,521	-7%	-$9.74M	1.97%	14
2020 Q3	$127M	Buy	1,223,549 +470,461	+62%	+$47.2M	2%	16
2020 Q2	$69.1M	Buy	753,088 +34,709	+5%	+$3.33M	1.06%	40
2020 Q1	$64.8M	Buy	718,379 +627,171	+688%	+$66.7M	1.08%	36
2019 Q4	$10.3M	Buy	91,208 +2,954	+3%	+$324K	0.12%	92
2019 Q3	$9.59M	Sell	88,254 -1,455	-2%	-$152K	0.12%	93
2019 Q2	$8.9M	Sell	89,709 -324	-0.4%	-$29.6K	0.1%	93
2019 Q1	$8.2M	Buy	90,033 +339	+0.4%	+$30.3K	0.12%	91
2018 Q4	$8.16M	Buy	89,694 +1,439	+2%	+$134K	0.13%	96
2018 Q3	$8.68M	Buy	88,255 +2,392	+3%	+$221K	0.11%	94
2018 Q2	$7.35M	Sell	85,863 -530	-0.6%	-$44.3K	0.09%	97
2018 Q1	$6.93M	Buy	86,393 +209	+0.2%	+$17.2K	0.08%	105
2017 Q4	$6.96M	Sell	86,184 -1,045	-1%	-$83.7K	0.08%	108
2017 Q3	$6.78M	Sell	87,229 -7,060	-7%	-$586K	0.08%	103
2017 Q2	$8.37M	Sell	94,289 -11,830	-11%	-$998K	0.1%	93
2017 Q1	$8.55M	Buy	106,119 +6	+0%	+$469	0.11%	92
2016 Q4	$7.56M	Sell	106,113 -3,205	-3%	-$252K	0.1%	96
2016 Q3	$9.45M	Sell	109,318 -310	-0.3%	-$27K	0.11%	85
2016 Q2	$9.51M	Sell	109,628 -2,857	-3%	-$231K	0.12%	81
2016 Q1	$8.44M	Sell	112,485 -683	-0.6%	-$51.4K	0.1%	79
2015 Q4	$8.71M	Sell	113,168 -5,498	-5%	-$414K	0.1%	84
2015 Q3	$7.94M	Sell	118,666 -1,645	-1%	-$121K	0.09%	89
2015 Q2	$8.91M	Sell	120,311 -19,367	-14%	-$1.48M	0.09%	97
2015 Q1	$10.9M	Buy	139,678 +33,166	+31%	+$2.51M	0.11%	84
2014 Q4	$7.69M	Sell	106,512 -4,796	-4%	-$333K	0.1%	88
2014 Q3	$6.9M	Buy	111,308 +84	+0.1%	+$5.34K	0.07%	114
2014 Q2	$7.09M	Sell	111,224 -1,381	-1%	-$83.9K	0.07%	117
2014 Q1	$6.93M	Sell	112,605 -5,147	-4%	-$300K	0.07%	119
2013 Q4	$6.76M	Sell	117,752 -1,646	-1%	-$93.3K	0.07%	119
2013 Q3	$6.36M	Sell	119,398 -1,841	-2%	-$99.1K	0.07%	120
2013 Q2	$6.24M	Buy	+121,239	New	+$5.99M	0.07%	119

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schafer Cullen Capital Management's MDT Position: Q1 2021 in Review

Schafer Cullen Capital Management reduced its Medtronic (MDT) stake by 93% in Q1 2021, selling an estimated $124M and leaving 74,080 shares worth $8.75M. The position accounts for 1.78% of the portfolio, ranked #27.

Schafer Cullen Capital Management first reported a position in MDT in Q2 2013 and has held it in 32 quarters since. The position peaked at $133M in Q4 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

Schafer Cullen Capital Management held 74,080 shares of Medtronic worth $8.75M as of Q1 2021.
Schafer Cullen Capital Management sold 1,060,948 Medtronic shares in Q1 2021, an estimated $124M.
Medtronic made up 1.78% of Schafer Cullen Capital Management's portfolio in Q1 2021, its #27 holding.
Schafer Cullen Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 32 quarters since.
Schafer Cullen Capital Management's Medtronic position peaked at $133M in Q4 2020.
1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.